Gastroenterology

Latest News

Australian doctor and biosimilars | Image credit: Sandor Kacso - stock.adobe.com
Australian Patients With IBD Switched to Biosimilar Infliximab Maintain Long-Term Persistence

July 5th 2025

Long-term data from the SAME study confirm that switching to infliximab biosimilars is safe and effective for patients with inflammatory bowel disease (IBD).

Smart phone app that tracks medical data | Image Credit: Maksym - stock.adobe.com
Adalimumab Double Take: The Unexpected Return to Reference Humira

June 30th 2025

child with IBD | Image credit: Art_Photo - stock.adobe.com
Increasing Biosimilar Use Reflects Changing Practice in Pediatric IBD Care

June 25th 2025

child with IBD getting adalimumab biosimilar | Image credit: zinkevych - stock.adobe.com
Long-Term Durability and Cost-Effectiveness of Adalimumab Biosimilars in Pediatric IBD

June 22nd 2025

EOP thumbnail
Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan

June 17th 2025

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
cfb podcast banner

More News

© 2025 MJH Life Sciences

All rights reserved.